Report supports tackling tobacco consumption, improving vaccination access to reduce global cancer burden

March 7, 2013 in Cancer

Combating the tobacco industry's tactics in the world's poorest countries as well as ensuring the best cancer vaccines are available to those most in need are key in order to reduce the number of cancer deaths worldwide, according to a new report published in the journal Science Translational Medicine.

The report presents the conclusions of the first ever meeting of senior representatives of major cancer research organisations from countries across the world, representing more than half of the world's population.

Tobacco remains the main driver of the cancer burden globally and the authors, Dr Harpal Kumar, Cancer Research UK's chief executive and Dr Harold Varmus, director of the in the USA, are urging governments throughout the world to put their citizens' health above the financial gains they reap from .

Recommended measures include putting higher taxes on the sale of tobacco products, ensuring health professionals set an example by stopping smoking, deglamourising the habit and protecting the poorest countries from increased marketing by the industry.

The authors also state that more needs to be done to ensure optimal access and uptake of the to protect against is as high as it can be. For example, the numbers having the vaccine is low in most countries, including developed countries such as the United States, where only a third of teenage girls are being vaccinated.

The report also calls for more research into vaccines for other cancer causing infections, such as and the Epstein-Barr viruses.

The paper also raises the following as vital areas that governments across the world should focus on

  • Ensuring there are national cancer plans and adequate cancer registration in all countries.
  • Improved funding for treatment.
  • Making it easier for people to run clinical trials internationally.
  • Making research papers open access and opposing the patenting of genes and gene mutations.
Worldwide, 12.7million people are diagnosed with cancer every year. And cancer now accounts for more than 15 per cent of the world's annual deaths.

Dr Kumar said: "This is the first time leading research organisations across the world have come together to consider how best to address the rapidly growing global burden of cancer. The number of people diagnosed with cancer across the world is increasing. But there are clear actions that all countries can take which will go a long way to reducing both the numbers diagnosed from cancer and deaths from the disease."

More information: Kumar and Varmas. Leaders of cancer research organizations from many nations propose measures to address the growing international challenge of cancer, Science and Translational Medicine (2013).

Journal reference: Science Translational Medicine search and more info website

Provided by Cancer Research UK search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

American cancer society celebrates 100 years of progress

(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.

Cancer created 2 hours ago | popularity not rated yet | comments 0

CT detects twice as many lung cancers as X-ray at initial screening exam

National Lung Screening Trial (NLST) investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening previously reported in the ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Research offers promising new approach to treatment of lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...

Cancer created 5 hours ago | popularity not rated yet | comments 0 | with audio podcast

Study details genes that control whether tumors adapt or die when faced with p53 activating drugs

When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...

Cancer created 6 hours ago | popularity not rated yet | comments 0 | with audio podcast

Small increase in cancer risk following CT scans in childhood and adolescence

Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.

Cancer created 10 hours ago | popularity not rated yet | comments 0


Calorie information in fast food restaurants used by 40 percent of 9-18 year olds when making food choices

A new study published online today (Thursday) in the Journal of Public Health has found that of young people who visited fast food or chain restaurants in the U.S. in 2010, girls and youth who were obese were more likely ...

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.